NY-TAKTILE
Taktile, recently named category leader in Decision Management Platforms by G2, is proud to announce the appointment of Jason Mikula as Head of Industry Strategy for Banking and Fintech. Mikula, who is a well-known industry thought leader, publishing his Fintech Business Weekly newsletter, a frequent guest on popular podcasts, and a sought-after speaker and moderator at marquee industry events, will help the company further innovate its product, go-to-market, and communications strategy for the financial services industry.
Mikula has nearly 15 years of experience in financial services and has previously served as a Vice President at Goldman Sachs, working in customer acquisition marketing and product management for the world-renowned investment bank’s retail effort, Marcus, where he worked on both lending and savings products. Mikula also has extensive experience in small-dollar lending, having worked at Enova and LendUp, as well as experience in private student lending and credit card programs.
In addition to his responsibilities as Head of Industry Strategy for Banking and Fintech at Taktile, Mikula serves as a mentor with the Techstars-ABN Amro Future of Finance accelerator program based in Amsterdam and will continue to publish Fintech Business Weekly.
“We’re thrilled to welcome Jason to Taktile,” said company co-founder and CEO Maik Taro Wehmeyer. “His deep experience in financial services and his unique familiarity with the entire ecosystem will allow us to fast-track our existing innovation momentum in the decisioning space. And right now, at a time of an unprecedented pace of product innovation in fintech and the emergence of various flavors of AI in real-life applications, the timing couldn’t be better.”
“I’m looking forward to jumping in head first,” said Mikula. “I spent more than 10 years interfacing with credit and fraud risk teams and thinking about how to optimize user journeys from application to approval and repayment. Now, I have the opportunity to go deep and influence the creation of the next generation of significantly more agile decisioning platforms and enable companies to iterate towards better decisions for themselves and their customers.”
About Taktile
Taktile is a next-generation risk decision platform that empowers subject matter experts to build, monitor, and experiment with automated decisions across the entire customer journey. Through advanced data analytics and machine learning, Taktile helps companies such as Mercury, Branch International, and Kueski make smarter, faster risk decisions and deliver innovative financial solutions to their customers. For more information, visit www.taktile.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240826269659/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Global Registry Data Show Meaningful Overall Survival Benefit in Patients with Advanced Cutaneous T-cell Lymphoma (CTCL) treated with POTELIGEO (mogamulizumab)22.10.2025 09:30:00 CEST | Press release
The PROCLIPI study, one of the largest studies to date in cutaneous T-cell lymphoma (CTCL), is a prospective, observational, multicentre international registry spanning 19 countries and includes over 2,000 patients, collects data to develop prognostic indices for CTCL1An analysis of 371 patients observed meaningful overall survival (OS) benefit for patients with advanced mycosis fungoides (MF) and Sézary syndrome (SS) treated with POTELIGEO (mogamulizumab)1,2,3Findings align with earlier survival signals and highlight how global collaboration can generate meaningful evidence in rare conditions such as MF and SS4,5Results were presented at this year’s European Organisation for Research and Treatment of Cancer - Cutaneous Lymphoma Tumour Group (EORTC-CLTG) Annual Meeting in Athens, Greece2 Kyowa Kirin International (KKI), a wholly owned subsidiary of Kyowa Kirin Co., Ltd. (TSE:4151, Kyowa Kirin), a Japan-based global specialty pharmaceutical company, and the University Hospitals Birmingh
World First: H-UKR 0% Clinker Cement Obtains Technical Assessment (ATec) for Wind Turbine Foundations22.10.2025 08:00:00 CEST | Press release
Hoffmann Green Cement Technologies (ISIN: FR0013451044, Ticker: ALHGR) (“Hoffmann Green Cement” or the “Company”), an industrial player committed to the decarbonation of the construction sector that designs and markets innovative cold produced, clinker-free cements, today announces that it has obtained a Technical Assessment (ATec) validating the use of its H-UKR decarbonized cement for wind turbine foundations. This unprecedented recognition, a world first for a 0% clinker cement, certifies that the H-UKR solution meets the highest standards of sustainability, safety, and performance for particularly rigorous applications such as wind power. A strategic step towards new markets This certification marks another key milestone for Hoffmann Green, enabling it to further accelerate its growth in the renewable energy market from 2026 and beyond. Obtaining this ATec certification paves the way for new commercial opportunities in this sector, strengthening its insurability with project owners
Takeda Enters Global Strategic Partnership with Innovent Biologics to Bolster Oncology Pipeline with Next-Generation Investigational Medicines for Treatment of Solid Tumors22.10.2025 02:25:00 CEST | Press release
Takeda to Receive Rights to Two Next-Generation Late-Stage Investigational Medicines, Worldwide Outside of Greater China, and an Exclusive Option to License Global Rights to an Early-Stage ProgramTakeda to Lead IBI363 Global Co-Development and U.S. Co-Commercialization and Will Have Exclusive Commercialization Rights Outside the U.S. and Greater China; IBI363 is a Late-Stage Bispecific Antibody Fusion Protein Being Evaluated in Non-Small Cell Lung and Colorectal Cancers, with Potential in Additional Solid Tumor TypesTakeda to Receive Exclusive Rights for IBI343 Outside of Greater China; IBI343 is a Late-Stage Antibody-Drug Conjugate Being Evaluated in Gastric and Pancreatic CancersTakeda Intends to Establish Manufacturing for These Investigational Medicines in the U.S. Takeda (TSE:4502/NYSE:TAK) today announced that it has entered into a license and collaboration agreement with Innovent Biologics (HKEX: 01801) for the development, manufacturing and commercialization of two late-stage o
YES Selected to Deliver Full Portfolio of Advanced Packaging Tools for Glass Panel AI and HPC Applications by a Leading AI Infrastructure Supplier21.10.2025 21:16:00 CEST | Press release
Yield Engineering Systems (YES), a leading provider of advanced process equipment for AI and high-performance computing (HPC) semiconductor applications, today announced that it has received multiple tool orders from a global leader in AI infrastructure solutions. The orders span YES’s portfolio of Dry and Wet process systems and will support panel-level manufacturing on glass substrates for next-generation data center and HPC packaging. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251020459437/en/ YES VertaCure, VertaPrime, VeroFlex, TersOra, and SURE systems. The systems will be deployed in advanced packaging lines dedicated to hyperscale AI workloads, including training, inference, networking, and co-packaged optics. This award marks a significant milestone in the industry's shift toward glass-based 2.5D and 3D packaging as system performance, density, and thermal requirements escalate. YES will supply a full suite of s
Esri and UNFPA Extend Strategic Partnership to Support 2030 Census Round21.10.2025 21:09:00 CEST | Press release
Collaboration Strengthens Census Through Location-Enabled Data Sharing Esri, the global leader in location intelligence, today announced the extension of its strategic partnership with the United Nations Population Fund (UNFPA) in support of the 2030 census round. Building on a successful collaboration during the 2020 census round, the partnership aims to embed geographic information system (GIS) technology into all phases of census work. By leveraging GIS, national statistics and census offices will gain access to more authoritative, location-enabled data and faster, more efficient methods of planning, collection, and dissemination. “National census projects can often involve mapping an entire country,” said Linda Peters, Esri global business development manager. “GIS is becoming crucial for every step of a census but deploying it is new to many national statistical offices. We are happy to provide the resources that can enable this large-scale feat of authoritative data collection an
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom